Home > Press Releases > Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market Likely to Surpass USD 5.9 Billion by 2035

Report Code: HC-50813  |  Published in: Mar 2026, By MarketGenics  |  Number of pages: 333

Global Urinary Incontinence Treatment Devices Market Forecast 2035:

According to the report, the global urinary incontinence treatment devices market is projected to expand from USD 2.7 billion in 2025 to USD 5.9 billion by 2035, registering a CAGR of 9.4%, the highest during the forecast period. The global urinary incontinence treatment devices market addresses a wide range of medical solutions designed to manage and treat urinary incontinence across different patient groups. The market includes devices such as catheters, pelvic floor stimulators, urethral slings, artificial urinary sphincters, and neuromodulation systems, catering to both conservative and surgical treatment approaches.

Market growth is primarily driven by the increasing prevalence of urinary incontinence associated with aging populations, chronic diseases, and lifestyle changes. Rising awareness about quality-of-life improvements, along with greater acceptance of medical intervention, is encouraging more patients to seek timely treatment. Technological advancements have led to the development of minimally invasive, patient-friendly, and home-use devices, improving treatment outcomes and patient compliance.

Additionally, the growing focus on home healthcare and integration of digital health technologies supports wider adoption of urinary incontinence treatment devices. Despite challenges such as social stigma and cost concerns, continuous innovation and expanding clinical applications are expected to sustain market growth and enhance long-term adoption globally.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Urinary Incontinence Treatment Devices Market”

Rapid urbanization is a key driver for the urinary incontinence treatment devices market, as sedentary lifestyles, increasing obesity, high stress levels, and poor dietary habits elevate the risk of urinary incontinence. Additionally, better access to healthcare infrastructure, specialized urology clinics, and homecare services in urban regions supports early diagnosis and higher adoption of advanced urinary incontinence treatment devices.

Social stigma and embarrassment associated with urinary incontinence act as a major restraint for the urinary incontinence treatment devices market. Many patients delay seeking medical advice due to fear of social judgment, leading to underdiagnosis and untreated conditions. This hesitation reduces awareness and acceptance of device-based treatments, limiting adoption rates despite the availability of effective and advanced therapeutic solutions.

The expansion of home-based care and telehealth presents a strong opportunity for the urinary incontinence treatment devices market. Integration of remote monitoring, virtual consultations, and connected devices enables personalized treatment plans, improves patient adherence, and reduces dependency on hospital visits. This approach expands market reach, particularly among elderly and mobility-limited patients, driving adoption of user-friendly and smart incontinence management solutions.

Expansion of Global Urinary Incontinence Treatment Devices Market

“Innovation that propel the global urinary incontinence treatment devices market expansion”

  • The urinary incontinence treatment devices market is experiencing rapid growth due to the rising prevalence of urinary incontinence, an aging global population, and increasing awareness about available treatment options. Technological advancements in minimally invasive and home-use devices, along with improved access to healthcare services, are further accelerating adoption.
  • Additionally, growing emphasis on quality of life and expanding reimbursement support in developed regions continue to drive sustained market expansion.

Regional Analysis of Global Urinary Incontinence Treatment Devices Market

  • North America leads the urinary incontinence treatment devices market due to the high prevalence of urinary incontinence, a rapidly aging population, and strong awareness about available treatment options. The region benefits from advanced healthcare infrastructure, widespread adoption of innovative medical devices, and the presence of leading manufacturers. Favorable reimbursement policies, higher healthcare spending, and early adoption of minimally invasive and home-based treatment solutions further support North America’s market dominance.
  • The Asia Pacific urinary incontinence treatment devices market is experiencing rapid growth driven by a rising elderly population, increasing prevalence of lifestyle-related disorders such as obesity and diabetes, and improving awareness of urinary incontinence treatments. Expanding healthcare infrastructure, growing medical tourism, and rising healthcare expenditure across emerging economies are enhancing access to advanced treatment devices. Additionally, increasing adoption of home-based care solutions and a large, underserved patient pool further accelerate regional market growth.

Prominent players operating in the global urinary incontinence treatment devices market are Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Coloplast Group, C.R. Bard (BD), Promedon Group, Cogentix Medical, American Medical Systems, Teleflex Incorporated, Cook Medical, Hollister Incorporated, ConvaTec Group plc, Wellspect HealthCare , B. Braun Melsungen AG, Axonics Modulation Technologies, Caldera Medical, Liberator Medical Supply, InControl Medical, Laborie Medical Technologies, Gedeon Richter Plc., Other Key Players.

The global urinary incontinence treatment devices market has been segmented as follows:

Global Urinary Incontinence Treatment Devices Market Analysis, By Device Type

  • Electrical Stimulation Devices
    • Percutaneous Tibial Nerve Stimulation (PTNS) Devices
    • Sacral Nerve Stimulation (SNS) Devices
    • Vaginal Electrical Stimulation Devices
    • Others
  • Urethral Slings
    • Mid-Urethral Slings
    • Traditional Slings
    • Adjustable Slings
  • Artificial Urinary Sphincters
  • Urethral Inserts
  • Vaginal Pessaries
  • Catheters
    • Intermittent Catheters
    • Indwelling Catheters
    • External Catheters
  • Bulking Agents Injection Devices

Global Urinary Incontinence Treatment Devices Market Analysis, By Technology

Global Urinary Incontinence Treatment Devices Market Analysis, By Rated Power (for Electrical Stimulation Devices)

  • Low Power (0-5 Watts)
  • Medium Power (5-15 Watts)
  • High Power (Above 15 Watts)

Global Urinary Incontinence Treatment Devices Market Analysis, By Rated Capacity (for Collection Devices)

  • Small Capacity (Up to 500 ml)
  • Medium Capacity (500-1000 ml)
  • Large Capacity (Above 1000 ml)

Global Urinary Incontinence Treatment Devices Market Analysis, By Incontinence Type

  • Stress Incontinence
  • Urge Incontinence
  • Overflow Incontinence
  • Functional Incontinence
  • Mixed Incontinence

Global Urinary Incontinence Treatment Devices Market Analysis, By Gender

  • Female-Specific Devices
  • Male-Specific Devices
  • Unisex Devices

Global Urinary Incontinence Treatment Devices Market Analysis, By Material Type

  • Silicone-Based
  • Polyurethane-Based
  • Polypropylene-Based
  • Metal Alloys
  • Bioabsorbable Materials
  • Hybrid Materials

Global Urinary Incontinence Treatment Devices Market Analysis, By Distribution Channel

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Medical Supply Stores
  • Direct Sales

Global Urinary Incontinence Treatment Devices Market Analysis, By End-Use

  • Hospitals
    • Surgical Implantation
    • Emergency Care
    • Outpatient Procedures
    • Diagnostic Evaluation
    • Post-Operative Management
    • Others
  • Specialty Clinics
  • Ambulatory Surgical Centers
    • Same-Day Surgical Procedures
    • Minimally Invasive Treatments
    • Follow-Up Care
    • Others
  • Home Care Settings
  • Nursing Homes & Assisted Living Facilities
  • Rehabilitation Centers
  • Diagnostic Centers
  • Other End-use

Global Urinary Incontinence Treatment Devices Market Analysis, By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Urinary Incontinence Treatment Devices Market Outlook
      • 2.1.1. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
    • 3.4. Trade Analysis
      • 3.4.1. Import & Export Analysis, 2025
      • 3.4.2. Top Importing Countries
      • 3.4.3. Top Exporting Countries
    • 3.5. Trump Tariff Impact Analysis
      • 3.5.1. Manufacturer
        • 3.5.1.1. Based on the component & Raw material
      • 3.5.2. Supply Chain
      • 3.5.3. End Consumer
    • 3.6. Raw Material Analysis
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Rising prevalence of urinary incontinence due to aging population and lifestyle-related conditions
        • 4.1.1.2. Growing adoption of minimally invasive and home-based incontinence treatment devices
        • 4.1.1.3. Increasing awareness, diagnosis rates, and demand for improved quality-of-life solutions
      • 4.1.2. Restraints
        • 4.1.2.1. Stringent regulatory approval processes and high compliance costs
        • 4.1.2.2. Social stigma and underreporting of urinary incontinence limiting treatment adoption
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Value Chain Analysis
      • 4.4.1. Component Suppliers
      • 4.4.2. Manufacturers
      • 4.4.3. System Integrators
      • 4.4.4. Sales Channel
      • 4.4.5. End-users
    • 4.5. PricingAnalysis
    • 4.6. CostingAnalysis
    • 4.7. Porter’s Five Forces Analysis
    • 4.8. PESTEL Analysis
    • 4.9. Global Urinary Incontinence Treatment Devices Market Demand
      • 4.9.1. Historical Market Size – Volume (Thousand Units) and Value (US$ Bn), 2020-2024
      • 4.9.2. Current and Future Market Size – Volume (Thousand Units) and Value (US$ Bn), 2026–2035
        • 4.9.2.1. Y-o-Y Growth Trends
        • 4.9.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Urinary Incontinence Treatment Devices Market Analysis, by Device Type
    • 6.1. Key Segment Analysis
    • 6.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Device Type, 2021-2035
      • 6.2.1. Electrical Stimulation Devices
        • 6.2.1.1. Percutaneous Tibial Nerve Stimulation (PTNS) Devices
        • 6.2.1.2. Sacral Nerve Stimulation (SNS) Devices
        • 6.2.1.3. Vaginal Electrical Stimulation Devices
        • 6.2.1.4. Others
      • 6.2.2. Urethral Slings
        • 6.2.2.1. Mid-Urethral Slings
        • 6.2.2.2. Traditional Slings
        • 6.2.2.3. Adjustable Slings
      • 6.2.3. Artificial Urinary Sphincters
      • 6.2.4. Urethral Inserts
      • 6.2.5. Vaginal Pessaries
      • 6.2.6. Catheters
        • 6.2.6.1. Intermittent Catheters
        • 6.2.6.2. Indwelling Catheters
        • 6.2.6.3. External Catheters
      • 6.2.7. Bulking Agents Injection Devices
  • 7. Global Urinary Incontinence Treatment Devices Market Analysis, by Technology
    • 7.1. Key Segment Analysis
    • 7.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Technology, 2021-2035
      • 7.2.1. Implantable Devices
      • 7.2.2. External Devices
      • 7.2.3. Minimally Invasive Devices
      • 7.2.4. Non-Invasive Devices
  • 8. Global Urinary Incontinence Treatment Devices Market Analysis, by Rated Power (for Electrical Stimulation Devices)
    • 8.1. Key Segment Analysis
    • 8.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Rated Power (for Electrical Stimulation Devices), 2021-2035
      • 8.2.1. Low Power (0-5 Watts)
      • 8.2.2. Medium Power (5-15 Watts)
      • 8.2.3. High Power (Above 15 Watts)
  • 9. Global Urinary Incontinence Treatment Devices Market Analysis, by Rated Capacity (for Collection Devices)
    • 9.1. Key Segment Analysis
    • 9.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Rated Capacity (for Collection Devices), 2021-2035
      • 9.2.1. Small Capacity (Up to 500 ml)
      • 9.2.2. Medium Capacity (500-1000 ml)
      • 9.2.3. Large Capacity (Above 1000 ml)
  • 10. Global Urinary Incontinence Treatment Devices Market Analysis, by Incontinence Type
    • 10.1. Key Segment Analysis
    • 10.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Incontinence Type, 2021-2035
      • 10.2.1. Stress Incontinence
      • 10.2.2. Urge Incontinence
      • 10.2.3. Overflow Incontinence
      • 10.2.4. Functional Incontinence
      • 10.2.5. Mixed Incontinence
  • 11. Global Urinary Incontinence Treatment Devices Market Analysis, by Gender
    • 11.1. Key Segment Analysis
    • 11.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Gender, 2021-2035
      • 11.2.1. Female-Specific Devices
      • 11.2.2. Male-Specific Devices
      • 11.2.3. Unisex Devices
  • 12. Global Urinary Incontinence Treatment Devices Market Analysis and Forecasts, by Material Type
    • 12.1. Key Findings
    • 12.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Material Type, 2021-2035
      • 12.2.1. Silicone-Based
      • 12.2.2. Polyurethane-Based
      • 12.2.3. Polypropylene-Based
      • 12.2.4. Metal Alloys
      • 12.2.5. Bioabsorbable Materials
      • 12.2.6. Hybrid Materials
  • 13. Global Urinary Incontinence Treatment Devices Market Analysis and Forecasts, by Distribution Channel
    • 13.1. Key Findings
    • 13.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Distribution Channel, 2021-2035
      • 13.2.1. Hospitals Pharmacies
      • 13.2.2. Retail Pharmacies
      • 13.2.3. Online Pharmacies
      • 13.2.4. Medical Supply Stores
      • 13.2.5. Direct Sales
  • 14. Global Urinary Incontinence Treatment Devices Market Analysis and Forecasts, by End-Use
    • 14.1. Key Findings
    • 14.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by End-Use, 2021-2035
      • 14.2.1. Hospitals
        • 14.2.1.1. Surgical Implantation
        • 14.2.1.2. Emergency Care
        • 14.2.1.3. Outpatient Procedures
        • 14.2.1.4. Diagnostic Evaluation
        • 14.2.1.5. Post-Operative Management
        • 14.2.1.6. Others
      • 14.2.2. Specialty Clinics
        • 14.2.2.1. Ambulatory Surgical Centers
        • 14.2.2.2. Same-Day Surgical Procedures
        • 14.2.2.3. Minimally Invasive Treatments
        • 14.2.2.4. Follow-Up Care
        • 14.2.2.5. Others
      • 14.2.3. Home Care Settings
      • 14.2.4. Nursing Homes & Assisted Living Facilities
      • 14.2.5. Rehabilitation Centers
      • 14.2.6. Diagnostic Centers
      • 14.2.7. Other End-use
  • 15. Global Urinary Incontinence Treatment Devices Market Analysis and Forecasts, by Region
    • 15.1. Key Findings
    • 15.2. Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 15.2.1. North America
      • 15.2.2. Europe
      • 15.2.3. Asia Pacific
      • 15.2.4. Middle East
      • 15.2.5. Africa
      • 15.2.6. South America
  • 16. North America Urinary Incontinence Treatment Devices Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. North America Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Device Type
      • 16.3.2. Technology
      • 16.3.3. Rated Power (for Electrical Stimulation Devices)
      • 16.3.4. Rated Capacity (for Collection Devices)
      • 16.3.5. Incontinence Type
      • 16.3.6. Gender
      • 16.3.7. Material Type
      • 16.3.8. Distribution Channel
      • 16.3.9. End-Use
      • 16.3.10. Country
        • 16.3.10.1. USA
        • 16.3.10.2. Canada
        • 16.3.10.3. Mexico
    • 16.4. USA Urinary Incontinence Treatment Devices Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Device Type
      • 16.4.3. Technology
      • 16.4.4. Rated Power (for Electrical Stimulation Devices)
      • 16.4.5. Rated Capacity (for Collection Devices)
      • 16.4.6. Incontinence Type
      • 16.4.7. Gender
      • 16.4.8. Material Type
      • 16.4.9. Distribution Channel
      • 16.4.10. End-Use
    • 16.5. Canada Urinary Incontinence Treatment Devices Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Device Type
      • 16.5.3. Technology
      • 16.5.4. Rated Power (for Electrical Stimulation Devices)
      • 16.5.5. Rated Capacity (for Collection Devices)
      • 16.5.6. Incontinence Type
      • 16.5.7. Gender
      • 16.5.8. Material Type
      • 16.5.9. Distribution Channel
      • 16.5.10. End-Use
    • 16.6. Mexico Urinary Incontinence Treatment Devices Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Device Type
      • 16.6.3. Technology
      • 16.6.4. Rated Power (for Electrical Stimulation Devices)
      • 16.6.5. Rated Capacity (for Collection Devices)
      • 16.6.6. Incontinence Type
      • 16.6.7. Gender
      • 16.6.8. Material Type
      • 16.6.9. Distribution Channel
      • 16.6.10. End-Use
  • 17. Europe Urinary Incontinence Treatment Devices Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Europe Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Device Type
      • 17.3.2. Technology
      • 17.3.3. Rated Power (for Electrical Stimulation Devices)
      • 17.3.4. Rated Capacity (for Collection Devices)
      • 17.3.5. Incontinence Type
      • 17.3.6. Gender
      • 17.3.7. Material Type
      • 17.3.8. Distribution Channel
      • 17.3.9. End-Use
      • 17.3.10. Country
        • 17.3.10.1. Germany
        • 17.3.10.2. United Kingdom
        • 17.3.10.3. France
        • 17.3.10.4. Italy
        • 17.3.10.5. Spain
        • 17.3.10.6. Netherlands
        • 17.3.10.7. Nordic Countries
        • 17.3.10.8. Poland
        • 17.3.10.9. Russia & CIS
        • 17.3.10.10. Rest of Europe
    • 17.4. Germany Urinary Incontinence Treatment Devices Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Device Type
      • 17.4.3. Technology
      • 17.4.4. Rated Power (for Electrical Stimulation Devices)
      • 17.4.5. Rated Capacity (for Collection Devices)
      • 17.4.6. Incontinence Type
      • 17.4.7. Gender
      • 17.4.8. Material Type
      • 17.4.9. Distribution Channel
      • 17.4.10. End-Use
    • 17.5. United Kingdom Urinary Incontinence Treatment Devices Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Device Type
      • 17.5.3. Technology
      • 17.5.4. Rated Power (for Electrical Stimulation Devices)
      • 17.5.5. Rated Capacity (for Collection Devices)
      • 17.5.6. Incontinence Type
      • 17.5.7. Gender
      • 17.5.8. Material Type
      • 17.5.9. Distribution Channel
      • 17.5.10. End-Use
    • 17.6. France Urinary Incontinence Treatment Devices Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Device Type
      • 17.6.3. Technology
      • 17.6.4. Rated Power (for Electrical Stimulation Devices)
      • 17.6.5. Rated Capacity (for Collection Devices)
      • 17.6.6. Incontinence Type
      • 17.6.7. Gender
      • 17.6.8. Material Type
      • 17.6.9. Distribution Channel
      • 17.6.10. End-Use
    • 17.7. Italy Urinary Incontinence Treatment Devices Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Device Type
      • 17.7.3. Technology
      • 17.7.4. Rated Power (for Electrical Stimulation Devices)
      • 17.7.5. Rated Capacity (for Collection Devices)
      • 17.7.6. Incontinence Type
      • 17.7.7. Gender
      • 17.7.8. Material Type
      • 17.7.9. Distribution Channel
      • 17.7.10. End-Use
    • 17.8. Spain Urinary Incontinence Treatment Devices Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Device Type
      • 17.8.3. Technology
      • 17.8.4. Rated Power (for Electrical Stimulation Devices)
      • 17.8.5. Rated Capacity (for Collection Devices)
      • 17.8.6. Incontinence Type
      • 17.8.7. Gender
      • 17.8.8. Material Type
      • 17.8.9. Distribution Channel
      • 17.8.10. End-Use
    • 17.9. Netherlands Urinary Incontinence Treatment Devices Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Device Type
      • 17.9.3. Technology
      • 17.9.4. Rated Power (for Electrical Stimulation Devices)
      • 17.9.5. Rated Capacity (for Collection Devices)
      • 17.9.6. Incontinence Type
      • 17.9.7. Gender
      • 17.9.8. Material Type
      • 17.9.9. Distribution Channel
      • 17.9.10. End-Use
    • 17.10. Nordic Countries Urinary Incontinence Treatment Devices Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Device Type
      • 17.10.3. Technology
      • 17.10.4. Rated Power (for Electrical Stimulation Devices)
      • 17.10.5. Rated Capacity (for Collection Devices)
      • 17.10.6. Incontinence Type
      • 17.10.7. Gender
      • 17.10.8. Material Type
      • 17.10.9. Distribution Channel
      • 17.10.10. End-Use
    • 17.11. Poland Urinary Incontinence Treatment Devices Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Device Type
      • 17.11.3. Technology
      • 17.11.4. Rated Power (for Electrical Stimulation Devices)
      • 17.11.5. Rated Capacity (for Collection Devices)
      • 17.11.6. Incontinence Type
      • 17.11.7. Gender
      • 17.11.8. Material Type
      • 17.11.9. Distribution Channel
      • 17.11.10. End-Use
    • 17.12. Russia & CIS Urinary Incontinence Treatment Devices Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Device Type
      • 17.12.3. Technology
      • 17.12.4. Rated Power (for Electrical Stimulation Devices)
      • 17.12.5. Rated Capacity (for Collection Devices)
      • 17.12.6. Incontinence Type
      • 17.12.7. Gender
      • 17.12.8. Material Type
      • 17.12.9. Distribution Channel
      • 17.12.10. End-Use
    • 17.13. Rest of Europe Urinary Incontinence Treatment Devices Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Device Type
      • 17.13.3. Technology
      • 17.13.4. Rated Power (for Electrical Stimulation Devices)
      • 17.13.5. Rated Capacity (for Collection Devices)
      • 17.13.6. Incontinence Type
      • 17.13.7. Gender
      • 17.13.8. Material Type
      • 17.13.9. Distribution Channel
      • 17.13.10. End-Use
  • 18. Asia Pacific Urinary Incontinence Treatment Devices Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Asia Pacific Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Device Type
      • 18.3.2. Technology
      • 18.3.3. Rated Power (for Electrical Stimulation Devices)
      • 18.3.4. Rated Capacity (for Collection Devices)
      • 18.3.5. Incontinence Type
      • 18.3.6. Gender
      • 18.3.7. Material Type
      • 18.3.8. Distribution Channel
      • 18.3.9. End-Use
      • 18.3.10. Country
        • 18.3.10.1. China
        • 18.3.10.2. India
        • 18.3.10.3. Japan
        • 18.3.10.4. South Korea
        • 18.3.10.5. Australia and New Zealand
        • 18.3.10.6. Indonesia
        • 18.3.10.7. Malaysia
        • 18.3.10.8. Thailand
        • 18.3.10.9. Vietnam
        • 18.3.10.10. Rest of Asia Pacific
    • 18.4. China Urinary Incontinence Treatment Devices Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Device Type
      • 18.4.3. Technology
      • 18.4.4. Rated Power (for Electrical Stimulation Devices)
      • 18.4.5. Rated Capacity (for Collection Devices)
      • 18.4.6. Incontinence Type
      • 18.4.7. Gender
      • 18.4.8. Material Type
      • 18.4.9. Distribution Channel
      • 18.4.10. End-Use
    • 18.5. India Urinary Incontinence Treatment Devices Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Device Type
      • 18.5.3. Technology
      • 18.5.4. Rated Power (for Electrical Stimulation Devices)
      • 18.5.5. Rated Capacity (for Collection Devices)
      • 18.5.6. Incontinence Type
      • 18.5.7. Gender
      • 18.5.8. Material Type
      • 18.5.9. Distribution Channel
      • 18.5.10. End-Use
    • 18.6. Japan Urinary Incontinence Treatment Devices Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Device Type
      • 18.6.3. Technology
      • 18.6.4. Rated Power (for Electrical Stimulation Devices)
      • 18.6.5. Rated Capacity (for Collection Devices)
      • 18.6.6. Incontinence Type
      • 18.6.7. Gender
      • 18.6.8. Material Type
      • 18.6.9. Distribution Channel
      • 18.6.10. End-Use
    • 18.7. South Korea Urinary Incontinence Treatment Devices Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Device Type
      • 18.7.3. Technology
      • 18.7.4. Rated Power (for Electrical Stimulation Devices)
      • 18.7.5. Rated Capacity (for Collection Devices)
      • 18.7.6. Incontinence Type
      • 18.7.7. Gender
      • 18.7.8. Material Type
      • 18.7.9. Distribution Channel
      • 18.7.10. End-Use
    • 18.8. Australia and New Zealand Urinary Incontinence Treatment Devices Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Device Type
      • 18.8.3. Technology
      • 18.8.4. Rated Power (for Electrical Stimulation Devices)
      • 18.8.5. Rated Capacity (for Collection Devices)
      • 18.8.6. Incontinence Type
      • 18.8.7. Gender
      • 18.8.8. Material Type
      • 18.8.9. Distribution Channel
      • 18.8.10. End-Use
    • 18.9. Indonesia Urinary Incontinence Treatment Devices Market
      • 18.9.1. Country Segmental Analysis
      • 18.9.2. Device Type
      • 18.9.3. Technology
      • 18.9.4. Rated Power (for Electrical Stimulation Devices)
      • 18.9.5. Rated Capacity (for Collection Devices)
      • 18.9.6. Incontinence Type
      • 18.9.7. Gender
      • 18.9.8. Material Type
      • 18.9.9. Distribution Channel
      • 18.9.10. End-Use
    • 18.10. Malaysia Urinary Incontinence Treatment Devices Market
      • 18.10.1. Country Segmental Analysis
      • 18.10.2. Device Type
      • 18.10.3. Technology
      • 18.10.4. Rated Power (for Electrical Stimulation Devices)
      • 18.10.5. Rated Capacity (for Collection Devices)
      • 18.10.6. Incontinence Type
      • 18.10.7. Gender
      • 18.10.8. Material Type
      • 18.10.9. Distribution Channel
      • 18.10.10. End-Use
    • 18.11. Thailand Urinary Incontinence Treatment Devices Market
      • 18.11.1. Country Segmental Analysis
      • 18.11.2. Device Type
      • 18.11.3. Technology
      • 18.11.4. Rated Power (for Electrical Stimulation Devices)
      • 18.11.5. Rated Capacity (for Collection Devices)
      • 18.11.6. Incontinence Type
      • 18.11.7. Gender
      • 18.11.8. Material Type
      • 18.11.9. Distribution Channel
      • 18.11.10. End-Use
    • 18.12. Vietnam Urinary Incontinence Treatment Devices Market
      • 18.12.1. Country Segmental Analysis
      • 18.12.2. Device Type
      • 18.12.3. Technology
      • 18.12.4. Rated Power (for Electrical Stimulation Devices)
      • 18.12.5. Rated Capacity (for Collection Devices)
      • 18.12.6. Incontinence Type
      • 18.12.7. Gender
      • 18.12.8. Material Type
      • 18.12.9. Distribution Channel
      • 18.12.10. End-Use
    • 18.13. Rest of Asia Pacific Urinary Incontinence Treatment Devices Market
      • 18.13.1. Country Segmental Analysis
      • 18.13.2. Device Type
      • 18.13.3. Technology
      • 18.13.4. Rated Power (for Electrical Stimulation Devices)
      • 18.13.5. Rated Capacity (for Collection Devices)
      • 18.13.6. Incontinence Type
      • 18.13.7. Gender
      • 18.13.8. Material Type
      • 18.13.9. Distribution Channel
      • 18.13.10. End-Use
  • 19. Middle East Urinary Incontinence Treatment Devices Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Middle East Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Device Type
      • 19.3.2. Technology
      • 19.3.3. Rated Power (for Electrical Stimulation Devices)
      • 19.3.4. Rated Capacity (for Collection Devices)
      • 19.3.5. Incontinence Type
      • 19.3.6. Gender
      • 19.3.7. Material Type
      • 19.3.8. Distribution Channel
      • 19.3.9. End-Use
      • 19.3.10. Country
        • 19.3.10.1. Turkey
        • 19.3.10.2. UAE
        • 19.3.10.3. Saudi Arabia
        • 19.3.10.4. Israel
        • 19.3.10.5. Rest of Middle East
    • 19.4. Turkey Urinary Incontinence Treatment Devices Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Device Type
      • 19.4.3. Technology
      • 19.4.4. Rated Power (for Electrical Stimulation Devices)
      • 19.4.5. Rated Capacity (for Collection Devices)
      • 19.4.6. Incontinence Type
      • 19.4.7. Gender
      • 19.4.8. Material Type
      • 19.4.9. Distribution Channel
      • 19.4.10. End-Use
    • 19.5. UAE Urinary Incontinence Treatment Devices Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Device Type
      • 19.5.3. Technology
      • 19.5.4. Rated Power (for Electrical Stimulation Devices)
      • 19.5.5. Rated Capacity (for Collection Devices)
      • 19.5.6. Incontinence Type
      • 19.5.7. Gender
      • 19.5.8. Material Type
      • 19.5.9. Distribution Channel
      • 19.5.10. End-Use
    • 19.6. Saudi Arabia Urinary Incontinence Treatment Devices Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Device Type
      • 19.6.3. Technology
      • 19.6.4. Rated Power (for Electrical Stimulation Devices)
      • 19.6.5. Rated Capacity (for Collection Devices)
      • 19.6.6. Incontinence Type
      • 19.6.7. Gender
      • 19.6.8. Material Type
      • 19.6.9. Distribution Channel
      • 19.6.10. End-Use
    • 19.7. Israel Urinary Incontinence Treatment Devices Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Device Type
      • 19.7.3. Technology
      • 19.7.4. Rated Power (for Electrical Stimulation Devices)
      • 19.7.5. Rated Capacity (for Collection Devices)
      • 19.7.6. Incontinence Type
      • 19.7.7. Gender
      • 19.7.8. Material Type
      • 19.7.9. Distribution Channel
      • 19.7.10. End-Use
    • 19.8. Rest of Middle East Urinary Incontinence Treatment Devices Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Device Type
      • 19.8.3. Technology
      • 19.8.4. Rated Power (for Electrical Stimulation Devices)
      • 19.8.5. Rated Capacity (for Collection Devices)
      • 19.8.6. Incontinence Type
      • 19.8.7. Gender
      • 19.8.8. Material Type
      • 19.8.9. Distribution Channel
      • 19.8.10. End-Use
  • 20. Africa Urinary Incontinence Treatment Devices Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. Africa Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Device Type
      • 20.3.2. Technology
      • 20.3.3. Rated Power (for Electrical Stimulation Devices)
      • 20.3.4. Rated Capacity (for Collection Devices)
      • 20.3.5. Incontinence Type
      • 20.3.6. Gender
      • 20.3.7. Material Type
      • 20.3.8. Distribution Channel
      • 20.3.9. End-Use
      • 20.3.10. Country
        • 20.3.10.1. South Africa
        • 20.3.10.2. Egypt
        • 20.3.10.3. Nigeria
        • 20.3.10.4. Algeria
        • 20.3.10.5. Rest of Africa
    • 20.4. South Africa Urinary Incontinence Treatment Devices Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Device Type
      • 20.4.3. Technology
      • 20.4.4. Rated Power (for Electrical Stimulation Devices)
      • 20.4.5. Rated Capacity (for Collection Devices)
      • 20.4.6. Incontinence Type
      • 20.4.7. Gender
      • 20.4.8. Material Type
      • 20.4.9. Distribution Channel
      • 20.4.10. End-Use
    • 20.5. Egypt Urinary Incontinence Treatment Devices Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Device Type
      • 20.5.3. Technology
      • 20.5.4. Rated Power (for Electrical Stimulation Devices)
      • 20.5.5. Rated Capacity (for Collection Devices)
      • 20.5.6. Incontinence Type
      • 20.5.7. Gender
      • 20.5.8. Material Type
      • 20.5.9. Distribution Channel
      • 20.5.10. End-Use
    • 20.6. Nigeria Urinary Incontinence Treatment Devices Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Device Type
      • 20.6.3. Technology
      • 20.6.4. Rated Power (for Electrical Stimulation Devices)
      • 20.6.5. Rated Capacity (for Collection Devices)
      • 20.6.6. Incontinence Type
      • 20.6.7. Gender
      • 20.6.8. Material Type
      • 20.6.9. Distribution Channel
      • 20.6.10. End-Use
    • 20.7. Algeria Urinary Incontinence Treatment Devices Market
      • 20.7.1. Country Segmental Analysis
      • 20.7.2. Device Type
      • 20.7.3. Technology
      • 20.7.4. Rated Power (for Electrical Stimulation Devices)
      • 20.7.5. Rated Capacity (for Collection Devices)
      • 20.7.6. Incontinence Type
      • 20.7.7. Gender
      • 20.7.8. Material Type
      • 20.7.9. Distribution Channel
      • 20.7.10. End-Use
    • 20.8. Rest of Africa Urinary Incontinence Treatment Devices Market
      • 20.8.1. Country Segmental Analysis
      • 20.8.2. Device Type
      • 20.8.3. Technology
      • 20.8.4. Rated Power (for Electrical Stimulation Devices)
      • 20.8.5. Rated Capacity (for Collection Devices)
      • 20.8.6. Incontinence Type
      • 20.8.7. Gender
      • 20.8.8. Material Type
      • 20.8.9. Distribution Channel
      • 20.8.10. End-Use
  • 21. South America Urinary Incontinence Treatment Devices Market Analysis
    • 21.1. Key Segment Analysis
    • 21.2. Regional Snapshot
    • 21.3. South America Urinary Incontinence Treatment Devices Market Size Volume (Thousand Units) and Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 21.3.1. Device Type
      • 21.3.2. Technology
      • 21.3.3. Rated Power (for Electrical Stimulation Devices)
      • 21.3.4. Rated Capacity (for Collection Devices)
      • 21.3.5. Incontinence Type
      • 21.3.6. Gender
      • 21.3.7. Material Type
      • 21.3.8. Distribution Channel
      • 21.3.9. End-Use
      • 21.3.10. Country
        • 21.3.10.1. Brazil
        • 21.3.10.2. Argentina
        • 21.3.10.3. Rest of South America
    • 21.4. Brazil Urinary Incontinence Treatment Devices Market
      • 21.4.1. Country Segmental Analysis
      • 21.4.2. Device Type
      • 21.4.3. Technology
      • 21.4.4. Rated Power (for Electrical Stimulation Devices)
      • 21.4.5. Rated Capacity (for Collection Devices)
      • 21.4.6. Incontinence Type
      • 21.4.7. Gender
      • 21.4.8. Material Type
      • 21.4.9. Distribution Channel
      • 21.4.10. End-Use
    • 21.5. Argentina Urinary Incontinence Treatment Devices Market
      • 21.5.1. Country Segmental Analysis
      • 21.5.2. Device Type
      • 21.5.3. Technology
      • 21.5.4. Rated Power (for Electrical Stimulation Devices)
      • 21.5.5. Rated Capacity (for Collection Devices)
      • 21.5.6. Incontinence Type
      • 21.5.7. Gender
      • 21.5.8. Material Type
      • 21.5.9. Distribution Channel
      • 21.5.10. End-Use
    • 21.6. Rest of South America Urinary Incontinence Treatment Devices Market
      • 21.6.1. Country Segmental Analysis
      • 21.6.2. Device Type
      • 21.6.3. Technology
      • 21.6.4. Rated Power (for Electrical Stimulation Devices)
      • 21.6.5. Rated Capacity (for Collection Devices)
      • 21.6.6. Incontinence Type
      • 21.6.7. Gender
      • 21.6.8. Material Type
      • 21.6.9. Distribution Channel
      • 21.6.10. End-Use
  • 22. Key Players/ Company Profile
    • 22.1. Boston Scientific Corporation
      • 22.1.1. Company Details/ Overview
      • 22.1.2. Company Financials
      • 22.1.3. Key Customers and Competitors
      • 22.1.4. Business/ Industry Portfolio
      • 22.1.5. Product Portfolio/ Specification Details
      • 22.1.6. Pricing Data
      • 22.1.7. Strategic Overview
      • 22.1.8. Recent Developments
    • 22.2. Medtronic plc
    • 22.3. Johnson & Johnson
    • 22.4. Coloplast Group
    • 22.5. C.R. Bard (BD)
    • 22.6. Promedon Group
    • 22.7. Cogentix Medical
    • 22.8. American Medical Systems
    • 22.9. Teleflex Incorporated
    • 22.10. Cook Medical
    • 22.11. Hollister Incorporated
    • 22.12. ConvaTec Group plc
    • 22.13. Wellspect HealthCare
    • 22.14. B. Braun Melsungen AG
    • 22.15. Axonics Modulation Technologies
    • 22.16. Caldera Medical
    • 22.17. Liberator Medical Supply
    • 22.18. InControl Medical
    • 22.19. Laborie Medical Technologies
    • 22.20. Gedeon Richter Plc.
    • 22.21. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation